NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NGNE NEUROGENE INC

休市中 10-16 16:00:00 EDT

23.25

-0.70

-2.92%

盘后23.25

+0.000.00%

19:30 EDT

最高24.27	最低23.00	成交量57.15万
今开24.00	昨收23.95	日振幅5.30%
总市值4.65亿	流通市值2.64亿	总股本2,001万
成交额1,342万	换手率5.04%	流通股本1,134万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":23.25,"timestamp":1792180800000,"preClose":23.95,"halted":0,"volume":571531,"hourTrading":{"tag":"盘后","latestPrice":23.25,"preClose":23.25,"latestTime":"19:30 EDT","volume":27647,"amount":642792.45,"timestamp":1792193404837,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.029227557411273457,"floatShares":11340900,"shares":20011400,"eps":-5.044019,"marketStatus":"休市中","change":-0.7,"latestTime":"10-16 16:00:00 EDT","open":24,"high":24.27,"low":23,"amount":13416072.399989,"amplitude":0.053027,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.044019,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":23.95,"preHourTrading":{"tag":"盘前","latestPrice":24.7078,"preClose":23.95,"latestTime":"08:33 EDT","volume":100,"amount":2470.7799999999997,"timestamp":1792154022168,"change":0.7578,"changeRate":0.031641,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":23.25,"preClose":23.25,"latestTime":"19:30 EDT","volume":27647,"amount":642792.45,"timestamp":1792193404837,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1873777890554669,"impliedVol":0.8715,"impliedVolPercentile":0.506},"requestUrl":"/m/hq/s/NGNE","defaultTab":"news","newsList":[{"id":"1116789187","title":"Neurogene第二季度运营支出达3667万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116789187","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116789187?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:46","pubTimestamp":1786448789,"startTime":"0","endTime":"0","summary":"8月11日（路透社）——Neurogene（NEUROGENE INC）第二季度净亏损达3448.8万美元。与此同时，该公司运营支出高达3667万美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114263724","title":"NEUROGENE INC提交新股发行及预融资认股权证发售申请，具体规模未予披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1114263724","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114263724?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:28","pubTimestamp":1782851328,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，NEUROGENE INC已正式提交了普通股发行以及用于购买普通股的预融资认股权证的发售申请。此次发行计划的具体规模尚未公开披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103826261","title":"Neurogene 融资所得将用于支持 Ngn-401 研发、商业化前期活动及一般公司运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1103826261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103826261?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:02","pubTimestamp":1782849753,"startTime":"0","endTime":"0","summary":"Neurogene 公司宣布，其近期融资所获资金将专项用于推进其主打候选药物 Ngn-401 的研发进程，支持相关的商业化前期准备工作，并满足公司一般运营资金需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155830354","title":"Neurogene公布Ngn-401基因疗法治疗雷特综合征1/2期试验积极长期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1155830354","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155830354?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:01","pubTimestamp":1782730884,"startTime":"0","endTime":"0","summary":"Neurogene公司公布了其Ngn-401基因疗法用于治疗雷特综合征的1/2期临床试验的积极长期数据。该结果表明，该疗法在延长随访期内持续展现出良好的安全性与耐受性特征，为患者带来了持久的临床获益希望。数据的发布进一步增强了该创新疗法在应对这一严重神经发育障碍方面的潜力，为后续的临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193064772","title":"Neurogene宣布Ngn-401治疗Rett综合征的Embolden™注册试验成功完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1193064772","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193064772?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:33","pubTimestamp":1780918428,"startTime":"0","endTime":"0","summary":"NEUROGENE INC 已正式宣布，其针对Rett综合征的候选疗法Ngn-401，在名为Embolden™的关键注册试验中成功完成了患者给药阶段。这一里程碑标志着该基因疗法在通往监管审批的道路上迈出了至关重要的一步，为受这一严重神经系统疾病困扰的患者家庭带来了新的希望。试验的顺利推进，为后续的数据收集与分析、以及最终向监管机构提交申请奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174324172","title":"Neurogene任命Christy Shafer为首席商务官，Christine Mikail加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1174324172","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174324172?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:31","pubTimestamp":1776684682,"startTime":"0","endTime":"0","summary":"基因治疗公司Neurogene Inc.宣布两项重要人事任命：Christy Shafer将出任公司首席商务官，负责全球商业化战略布局；同时，具有法律背景的Christine Mikail将加入董事会担任独立董事。此次人事变动凸显了Neurogene在推进罕见病基因疗法商业化进程中的战略部署。Shafer在生物制药领域拥有超过20年的商业化经验，曾主导多款罕见病药物的全球市场投放；而Mikail在企业治理和合规领域的专业背景，将助力公司完善决策机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516843668","title":"Neurogene Inc.盘中异动 下午盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516843668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516843668?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:51","pubTimestamp":1741031501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时51分，Neurogene Inc.股票出现波动，股价急速下跌5.20%。截至发稿，该股报16.77美元/股，成交量10.9309万股，换手率0.74%，振幅4.38%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4566.04%、209.35%、182.07%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035141a25d987e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035141a25d987e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512416511","title":"Neurogene Inc.盘中异动 早盘股价大涨5.07%报19.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512416511?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Neurogene Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报19.35美元/股，成交量1300股，换手率0.01%，振幅2.06%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.65%、90.83%、59.47%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、6.84%、6.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380589","title":"Neurogene Inc.盘中异动 早盘快速下跌5.45%报17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380589?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284500,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，Neurogene Inc.股票出现波动，股价大幅跳水5.45%。截至发稿，该股报17.86美元/股，成交量2885股，换手率0.02%，振幅4.24%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2065.81%、542.56%、180.31%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、知临集团，振幅分别为25.06%、22.23%、16.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235009881bd91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235009881bd91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509120601","title":"Neurogene Inc.盘中异动 临近午盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509120601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509120601?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:40","pubTimestamp":1738860046,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时40分，Neurogene Inc.股票出现波动，股价大幅上涨5.29%。截至发稿，该股报22.67美元/股，成交量13.6563万股，换手率0.92%，振幅7.63%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Palatin Technologies, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5859.45%、1537.68%、155.64%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207004046961a2d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207004046961a2d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508814140","title":"Neurogene Inc.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508814140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508814140?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:58","pubTimestamp":1738598296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时58分，Neurogene Inc.股票出现异动，股价大幅上涨5.17%。截至发稿，该股报16.67美元/股，成交量4.2682万股，换手率0.29%，振幅9.21%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为567.15%、431.96%、357.83%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为167.11%、75.23%、57.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323581698797cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323581698797cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506830547","title":"Neurogene Inc.盘中异动 快速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506830547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506830547?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:41","pubTimestamp":1737988911,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时41分，Neurogene Inc.股票出现异动，股价大幅拉升5.18%。截至发稿，该股报15.84美元/股，成交量1.2708万股，换手率0.09%，振幅6.71%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Moolec Science Sa C/Wts 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为59.77%、58.03%、47.17%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.16%、53.97%、53.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224152a2316d2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224152a2316d2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505591861","title":"Neurogene Inc.盘中异动 早盘大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505591861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505591861?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:06","pubTimestamp":1737731165,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时06分，Neurogene Inc.股票出现波动，股价急速下挫5.12%。截至发稿，该股报14.78美元/股，成交量5.4892万股，换手率0.37%，振幅5.20%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Pmgc Holdings Inc.、Windtree Therapeutics, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Avenue Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为1668.24%、892.82%、746.48%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pmgc Holdings Inc.，振幅分别为66.25%、55.79%、52.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230605a22e6224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230605a22e6224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504119139","title":"Neurogene Inc.盘中异动 大幅下挫5.05%报16.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504119139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504119139?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:23","pubTimestamp":1737145434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时23分，Neurogene Inc.股票出现异动，股价大幅跳水5.05%。截至发稿，该股报16.74美元/股，成交量9.2235万股，换手率0.62%，振幅5.37%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Channel Therapeutics Corporation、Scorpius Holdings, Inc.较为活跃，换手率分别为245.66%、165.45%、85.45%，振幅较大的相关个股有Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Scorpius Holdings, Inc.，振幅分别为150.00%、117.68%、68.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118042354986a5cfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118042354986a5cfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504943311","title":"Neurogene Inc.盘中异动 急速下跌5.29%报17.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504943311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504943311?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:39","pubTimestamp":1737049165,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时39分，Neurogene Inc.股票出现波动，股价急速下挫5.29%。截至发稿，该股报17.56美元/股，成交量4.8599万股，换手率0.33%，振幅4.96%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.较为活跃，换手率分别为1888.63%、783.70%、670.79%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.，振幅分别为131.33%、104.84%、79.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117013926a22489d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117013926a22489d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640932","title":"Neurogene Inc.盘中异动 早盘股价大涨6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640932?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951539,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Neurogene Inc.股票出现波动，股价快速上涨6.82%。截至发稿，该股报19.11美元/股，成交量2250股，换手率0.02%，振幅0.34%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522322098673b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522322098673b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502703080","title":"Neurogene Inc.盘中异动 快速跳水5.54%报20.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502703080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502703080?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:21","pubTimestamp":1736356873,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时21分，Neurogene Inc.股票出现波动，股价大幅跳水5.54%。截至发稿，该股报20.65美元/股，成交量2.4265万股，换手率0.16%，振幅7.23%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Sana Biotechnology, Inc.、Vir Biotechnology, Inc.、Silo Pharma, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3421.45%、587.22%、586.94%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012114985f9521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012114985f9521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE","SANA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2495525611","title":"Neurogene Inc.盘中异动 早盘股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495525611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495525611?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:34","pubTimestamp":1735569289,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时34分，Neurogene Inc.股票出现异动，股价大幅跳水6.40%。截至发稿，该股报21.50美元/股，成交量1.1686万股，换手率0.08%，振幅0.04%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Vincerx Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Polyrizon Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Polyrizon Ltd.、Vincerx Pharma, Inc.较为活跃，换手率分别为689.68%、330.11%、101.60%，振幅较大的相关个股有Vor Biopharma Inc.、Sensei Biotherapeutics, Inc.、X4制药，振幅分别为106.30%、104.42%、103.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022345095f2c37e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022345095f2c37e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494865409","title":"Neurogene Inc.盘中异动 早盘股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494865409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494865409?lang=zh_cn&edition=full","pubTime":"2024-12-26 22:31","pubTimestamp":1735223480,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日22时31分，Neurogene Inc.股票出现波动，股价快速上涨5.66%。截至发稿，该股报23.90美元/股，成交量6046股，换手率0.04%，振幅0.04%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为1116.97%、156.98%、99.20%，振幅较大的相关个股有Viracta Therapeutics, Inc.、Neumora Therapeutics, Inc.、Tiziana Life Sciences Ltd，振幅分别为7.20%、6.77%、5.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226223120ab938bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226223120ab938bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494005705","title":"2025投资风向标，投行William Blair看涨这些股","url":"https://stock-news.laohu8.com/highlight/detail?id=2494005705","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494005705?lang=zh_cn&edition=full","pubTime":"2024-12-26 08:01","pubTimestamp":1735171262,"startTime":"0","endTime":"0","summary":"随着交易年接近尾声，投资银行William Blair建议投资者关注一些可能在2025年迎来大幅增长的股票。这种涨势可能延续到2025年，因为William Blair认为“略有改善”的行业环境可能为其股价提供助力。“我们预计，行业复苏以及线上迁移的持续正常化将在2025年带来显著的上涨空间，这两个因素目前都处于早期阶段，”William Blair表示。William Blair认为，这两项进展将推动其股价上涨。William Blair认为，这一决定尚未被华尔街充分重视。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/26080146824430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00B19Z9Z06.USD","LU2473716301.USD","LU0061474960.USD","LU0683600562.USD","LU1992135399.USD","SG9999015952.SGD","LU0417517546.SGD","LU2505996509.AUD","SG9999001424.SGD","BK4139","AVGO","LU0889565833.HKD","LU0081259029.USD","LU1934455863.HKD","LU0444971666.USD","LU2592432038.USD","CVNA","LU2272731600.USD","LU2279689827.SGD","LU0345770308.USD","IE00B42XCP33.USD","LU1989764748.USD","LU1037948897.HKD","LU2505996681.GBP","SGXZ23171101.USD","BK4588","LU1934455194.USD","LU0203345920.USD","LU0256863902.USD","LU0787776722.HKD","LU0096362180.USD","LU0256863811.USD","SG9999015945.SGD","SG9999015978.USD","LU0965509283.SGD","LU1852331112.SGD","LU0689472784.USD","IE00BMCWC346.EUR","CHWY","LU1670711040.USD","LU2458330169.SGD","LU0345769128.USD","LU1935043023.USD","NGNE","LU1720051108.HKD","LU2360106780.USD","BK4598","LU0965508806.USD","LU0320765646.SGD","LU1935042488.USD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.neurogene.com","stockEarnings":[{"period":"1week","weight":-0.1193},{"period":"1month","weight":-0.3294},{"period":"3month","weight":-0.3768},{"period":"6month","weight":-0.1652},{"period":"1year","weight":-0.316},{"period":"ytd","weight":0.1286}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neurogene Inc.最初于2007年5月在特拉华州以Aquinox Pharmaceuticals的名称注册成立，经过一系列合并和更名后，于2023年12月采用现名。该公司是一家临床阶段的生物技术公司，利用其专有的EXACT转基因调控技术，专注于为罕见神经系统疾病开发基因药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.03558},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.018567},{"month":3,"riseRate":0.416667,"avgChangeRate":0.022217},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.048366},{"month":5,"riseRate":0.538462,"avgChangeRate":0.007464},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.058237},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.047276},{"month":8,"riseRate":0.846154,"avgChangeRate":0.724623},{"month":9,"riseRate":0.230769,"avgChangeRate":-0.078178},{"month":10,"riseRate":0.384615,"avgChangeRate":0.006123},{"month":11,"riseRate":0.416667,"avgChangeRate":0.000025},{"month":12,"riseRate":0.583333,"avgChangeRate":0.147487}],"exchange":"NASDAQ","name":"NEUROGENE INC","nameEN":"NEUROGENE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NEUROGENE INC,NGNE,NEUROGENE INC股票,NEUROGENE INC股票老虎,NEUROGENE INC股票老虎国际,NEUROGENE INC行情,NEUROGENE INC股票行情,NEUROGENE INC股价,NEUROGENE INC股市,NEUROGENE INC股票价格,NEUROGENE INC股票交易,NEUROGENE INC股票购买,NEUROGENE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}